MedPath

Role of Adiponectin and Endothelial Progenitor Cells in Reperfusion Injury in Patients With Acute Myocardial Infarction

Completed
Conditions
Myocardial Infarction
Reperfusion Injury
Registration Number
NCT01414452
Lead Sponsor
Universiteit Antwerpen
Brief Summary

There is experimental evidence that low levels of adiponectin are associated with more reperfusion injury. In addition experimental studies have demonstrated that endothelial progenitor cells may have a favorable effect on remodeling, mainly through stimulation of neo-revascularisation. Clinical data on these issues are lacking. This clinical project studies the role of adiponectin, endothelial progenitor cells and endothelial microparticles in the ischaemia-reperfusion process and the compensatory ventricular remodelling in a population of 250 infarction patients treated with primary PCI. If the role of these factors could be confirmed in this clinical setting, those factors might represent a new target for therapeutic interventions in AMI patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria
  • STEMI treated with primary PCI
Exclusion Criteria
  • ischemia time >12h
  • use of immunosuppressive therapy
  • unsuccessful recanalisation
  • not-interpretable ST-T segment

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
occurrence of reperfusion injury after succesfull primary PCIwithin 90 min after PCI

Serial ECG measurements (before and after PCI to assess extent of ST segment resolution as marker of reperfusion injury

Secondary Outcome Measures
NameTimeMethod
Major cardiovascular event rateat 1 year

combined endpoint of hospitalisation (or extension of hospitalisation) for heart failure and cardiac death in a period of one year

Trial Locations

Locations (1)

University hospital

🇧🇪

Edegem, Antwerp, Belgium

© Copyright 2025. All Rights Reserved by MedPath